期刊文献+

慢性肝炎及肝硬化患者血小板计数的临床探讨

Investigation of clinical value of of platelet count in patients with chronic hepatitis and liver cirrhosis
暂未订购
导出
摘要 目的探讨血小板计数(PLT)在慢性肝炎及不同程度肝硬化患者中的变化及临床意义。方法采用日本SysmexSF-3000全自动血细胞分析仪对慢性肝炎60例及肝硬化患者60例(按Child-Pugh分级:A级21例,B级22例,C级17例)、健康对照组100例的PLT进行检测,并将各组的变化进行比较分析。结果慢性肝炎组和肝硬化组的PLT均显著减少(P<0.01),随着肝硬化进程PLT减少更显著,与A级相比,B、C级的PLT更有显著变化(P<0.01和P<0.001)。结论外周PLT对评估慢性肝病的严重程度、出血倾向有重要的指导作用。 Objective To investigate clinical significance of platelet count in patients with chronic hepatitis and liver cirrhosis. Methods Sixty patients with liver cirrhosis were graded as A (n=21), B (n=22) and C (n= 17) according to Child-Pugh categories. Sysmex SF-3000 Auto Hematology Analyzer was applied to performing platelet count in 60 patients with chronic hepatitis, 60 patients with liver cirrhosis and 100 healthy controls. Then the detective results were compared. Results PLT in chronic hepatitis group and liver cirrhosis group decreased significantly (P〈0.01). In liver cirrhosis group, with the development of disease, the PLT count kept decreasing. The differences were more significant in B, C grade group than in A grade group. Conclusion Platelet count may be helpful to evaluate the severity and hemorrhage trend of chronic liver diseases.
出处 《检验医学与临床》 CAS 2007年第6期486-487,共2页 Laboratory Medicine and Clinic
关键词 慢性肝炎 肝硬化 血小板计数 chronic hepatitis liver cirrhosis platelet count
  • 相关文献

参考文献4

二级参考文献17

  • 1[5]Zeldis JB,Farraye FA,Steinberg HN.In vitro hepatitis B virus suppression of erythropoiesis is dependent on the multiplicity of infection and is reversible with anti-HBS antibodies[J].Hepatology,1988,8(4):755-759.
  • 2[6]Floreani A,Biasin MR,Marchelle G,et al.Are human platelets a site of HCV replication[J]? Hepatology,1996,24S:511A.
  • 3顾长海,王宇明,主编.肝功能衰竭[J].北京:人民卫生出版社,2002,:238.
  • 4De Sauvage FJ, Luoh SM, Carver-Moore K, et al. Deficiencies in early and late stages megakaryocytopoiesis in TPO-KO mice. J Exp Med, 1996, 183: 651-656.
  • 5De Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.Nature, 1994, 369: 533-538.
  • 6Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost, 1998, 79:1106-1110.
  • 7Sanjo A, Satoi J, Ohnishi A, et al. Role of elevated platelet-associated immunoglobnlin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol, 2003, 18: 638-644.
  • 8Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood, 2002, 100: 3457-3469.
  • 9Goulis J, Chau TN, Jordan S, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia are restored after orthotopic liver transplantation. Gut, 1999, 44: 754-758.
  • 10Stockelberg D, Andersson P, Bjornsson E, et al. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J Intern Med,1999, 246: 471-475.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部